CVE-2022-30277
BD Synapsys™ – Insufficient Session Expiration
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
Attack profile
How easy it is to exploit
- Attack vector
- Physical
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- Required
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
BD Synapsys™ – Insufficient Session Expiration
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
- Record
CVE-2022-30277- CVSS 3.1
- 5.7 Medium
CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N - Weakness
- CWE-613
- Updated
- 2026-11-02
EUVDEUVD-2022-52232
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
- Record
EUVD-2022-52232- CVSS 3.1
- 5.7 Medium
CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N - Updated
- 2026-11-03
GitHub AdvisoriesGHSA-r2qv-r4vq-j8mm
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration...
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
- Record
GHSA-r2qv-r4vq-j8mm- CVSS 3.1
- 5.7 Medium
CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N - Weakness
- CWE-613
- Updated
- 2026-11-02
NVD
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
- Record
CVE-2022-30277- CVSS 3.1
- 5.7 Medium
CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N - CVSS 2.0
- 3.6 Low
AV:L/AC:L/Au:N/C:P/I:P/A:N - Weakness
- CWE-613
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases, published | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2022-30277 is a medium vulnerability (CVSS 5.7) in Bd Synapsys, published June 1, 2022. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.23%, the 14th percentile. No source names a fixed version.